Physician profile
David Manning
NPI 1275025793
$1,385.34
in general payments reported to CMS, 2019-2025
17 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $200 · 2023: $272 · 2024: $260 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $477.09 | 2021-2025 | Belbuca, Xtampza |
| Forte Bio-Pharma LLC | $139.13 | 2021-2024 | Prolate, Nalocet |
| Scilex Pharmaceuticals INC. | $139.01 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.89 | 2021-2025 | Relistor, Trulance |
| Indivior INC. | $79.17 | 2023-2025 | Sublocade |
| Valinor Pharma, LLC | $75.04 | 2025 | Movantik |
| Vertex Pharmaceuticals Incorporated | $64.63 | 2024-2025 | |
| Nevro Corp. | $61.93 | 2021-2023 | Senza |
| Uswm, LLC | $43.08 | 2022 | |
| Azurity Pharmaceuticals, INC. | $35.21 | 2023 | Horizant |
| Boston Scientific Corporation | $31.93 | 2022 | |
| Arbor Pharmaceuticals, INC. | $26.04 | 2021 | |
| Redhill Biopharma INC. | $24.96 | 2021 | |
| Braeburn INC. | $24.52 | 2025 | Brixadi |
| Ibsa Pharma INC. | $20.88 | 2023 | Tirosint, Licart |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $16.18 | 2022 | |
| Alkermes, INC. | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.